indoline has been researched along with abiraterone acetate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Candeias, NR; Kandhavelu, M; Le, HTT; Murugesan, A; Ramesh, T; Yli-Harja, O | 1 |
1 other study(ies) available for indoline and abiraterone acetate
Article | Year |
---|---|
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer.
Topics: Abiraterone Acetate; Androgen Receptor Antagonists; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Male; Prostatic Neoplasms; Purinergic P2Y Receptor Agonists; Receptors, Androgen; Receptors, Purinergic P2Y1 | 2022 |